Safety and efficacy of direct-acting antiviral drugs in the treatment of chronic hepatitis C virus infection in patients with thalassemia: a prospective study

Safety and efficacy of direct-acting antiviral drugs in the treatment of chronic hepatitis C virus infection in patients with thalassemia: a prospective study

Abstract Background Hepatitis C virus (HCV) infection is a major cause of liver-related morbidity and mortality among thalassemic patients. Direct-acting antiviral agents (DAAs) are highly effective and well-tolerated by chronic HCV patients. Results The mean age of our patients was 29 years. Sustai...

Full description

Bibliographic Details
Main Authors: Elsayed Ghoneem, Ahmed Saleh, Shahira Aly El-Etreby, Metwaly Ibrahim Mortada, Mayada A. Ghannam, Shaimaa El-Ashwah, Noha Eisa
Format: Article
Language:English
Published: SpringerOpen 2021-06-01
Series:Egyptian Liver Journal
Subjects:
Thalassemia
Chronic hepatitis C
Direct-acting antiviral drugs (DAAs)
Sustained virologic response (SVR)
Post-transfusion hepatitis (PTH)
Online Access:https://doi.org/10.1186/s43066-021-00124-5

Internet

https://doi.org/10.1186/s43066-021-00124-5

Similar Items